Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Veterinary API Import to Russia (First Half of 2020)

Wednesday, July 29, 2020

Between January and June 2020, Russia imported 1.17 bln RUB worth of veterinary APIs (customs clearance and VAT included), which is monetary terms (rubles) 7% lower than in 2019. The dynamics in physical terms (kilograms) are -25%, with the volume of 412 tons.

Dramatic changes in the demand for ready-made drugs did not cause the negative dynamics in both monetary and physical terms; the manufacturers have been using the stocks replenished at the end of 2019, when the dynamics were +70% in physical and +66% in monetary terms.

The import line has expanded from 60 to 78 INNs, with Russia stopping the import of 10 and starting the import of 28 new INNs.

Antibacterial Tylosinum was the most imported veterinary API in monetary terms between January and June 2020. It was imported by nine companies, including both distributors of pharmaceutical and veterinary raw materials and manufacturers of veterinary drugs, with Simbio having the largest import volume. Tylosinum is followed by another antibiotic Tiamulinum, which was imported by six companies, and Vetline accounted for the biggest volume. Tylosinum is imported to Russia from Bulgaria (57% of the total volume in monetary terms) and China (43%). China is also the only country that imports Tiamulinum to Russia.

Tylosinum and Tiamulinum were also ones of the most imported veterinary APIs in physical terms (first place and 12% for Tylosinum, and third place and 9.3% for Tiamulinum). Tylosinum is followed by Amoxicillinum, which also accounts for nearly 12% of the total import. Amoxicillinum was imported by six companies, among which Protek-SVM imported the largest volume. (Protek-SVM imports from India, while the others from China.)

Nita-Farm is the biggest importer of veterinary API in monetary terms, with 18% of the total import volume. The manufacturer imported 27 different INNs; Levofloxacinum and Flunixinum accounted for the largest volume. Protek-SVM and come second and third, with 11% and 10%, respectively. Protek-SVM imported 15 INNs (Amoxicillinum and Florfenicolum were their most imported APIs), and imported 21 (Tylosinum and Amoxicillinum accounted for the biggest volume).

Dynamics of veterinary API import to Russia (EEU countries excluded), free circulation prices including customs clearance and VAT (2016 – 2019, January – June 2020)